Metraipolis › archive › dc_cd0d98ca499e

Oral selective estrogen receptor degraders in ER+/HER2- breast cancer: a systematic review with pooled analysis of metastatic randomized trials and narrative… — Europe PMC PMID:42755923

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42755923
DOI: 10.3389/fonc.2026.1896847
License (as archived): solo-consultazione
Archived: 2026-10-16T06:00:40.630Z
SHA-256 of the archived text: a5bbb2a602376ad721b6b5d2fd81e156f3c3fac75b8aa615f195c72a9edcdf04
Stable URL of this page: https://metraipolis.com/documento/dc_cd0d98ca499e

How to cite

Oral selective estrogen receptor degraders in ER+/HER2- breast cancer: a systematic review with pooled analysis of metastatic randomized trials and narrative… — Europe PMC PMID:42755923 — Europe PMC (en), https://europepmc.org/article/MED/42755923 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd0d98ca499e (Metraipolis archive dc_cd0d98ca499e, sha256 a5bbb2a602376ad721b6b5d2fd81e156f3c3fac75b8aa615f195c72a9edcdf04)

BibTeX

@misc{dccd0d98ca499e,
  title = {Oral selective estrogen receptor degraders in ER+/HER2- breast cancer: a systematic review with pooled analysis of metastatic randomized trials and narrative… — Europe PMC PMID:42755923},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755923},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd0d98ca499e; sha256 a5bbb2a602376ad721b6b5d2fd81e156f3c3fac75b8aa615f195c72a9edcdf04},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755923. Agents can read the archived copy with the MCP tool read_document.